Integrating signals from the T-cell receptor and the interleukin-2 receptor.
T cells orchestrate the adaptive immune response, making them targets for immunotherapy.Although immunosuppressive therapies prevent disease progression, they also leave patients susceptible to opportunistic infections.To identify novel drug targets, we established a logical model describing T-cell receptor (TCR) signaling.However, to have a model